"Your cardiovascular health is our top priority. Our extensive team of physicians and healthcare professionals is dedicated to providing compassionate expert care as quickly and efficiently as possible."

During the past decade, Wellmont CVA Heart Institute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wellmont CVA Heart Institute" #1 collaborator was "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Wellmont CVA Heart Institute" are "Atherosclerotic Cardiovascular Disease" (2 trials), "Familial Hypercholesterolemia" (2 trials), "Cardiovascular Disease" (1 trials), "Diabetes" (1 trials) and "High Cardiovascular Risk" (1 trials). Many other conditions were trialed in "Wellmont CVA Heart Institute" in a lesser frequency.

Most popular intervention types in "Wellmont CVA Heart Institute" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "ALN-PCSSC" (1 trials), "Evolocumab" (1 trials), "Inclisiran" (1 trials), "Lorcaserin hydrochloride" (1 trials) and "Normal Saline" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wellmont CVA Heart Institute" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Wellmont CVA Heart Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Wellmont CVA Heart Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wellmont CVA Heart Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".